Subpart A. Subpart A—Drugs Regarded as Misbranded

• § 250.11 - Thyroid-containing drug preparations intended for treatment of obesity in humans.
• § 250.12 - Stramonium preparations labeled with directions for use in self-medication regarded as misbranded.